Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by coalbeton May 19, 2017 7:24pm

259 Views

Post# 26266745

Her's a few of many!

In mid-2003, Priceline.com (NASDAQ:PCLN) did a 1-for-6 reverse stock split, lifting its stock price from around $3.50 per share to $22, as many investors believed that the William Shatner-led Internet travel service would fade away with so many other dot-com companies. Now, 12 years later, the stock trades above $1,200 per share, giving long-term investors a 50-bagger with room to spare.
In 2000, Laboratory Corp. of America (NYSE:LH) did a 1-for-10 reverse split after having seen its stock stuck in single digits for more than five years. Within two years of the reverse split, LabCorp had not only recovered, but it had also done two separate 2-for-1 regular splits, and the stock now trades for six times its split-adjusted price immediately after the reverse split.
Corrections Corp. of America (NYSE:CXW) traded as low as $0.60 per share in 2001 before reverse-splitting 1-for-10. Since then, the private prison-services provider has seen its stock jump more than tenfold, with two regular splits helping to drive the company's total return higher.